<DOC>
	<DOCNO>NCT00697697</DOCNO>
	<brief_summary>The purpose study examine safety two dos MAP0010 asthmatic child , 12 month 8 year age , 40-week period .</brief_summary>
	<brief_title>A Study 2 Doses MAP0010 Asthmatic Children</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Completed 12 week treatment MAP0010CLP301 study . Patient , parent , guardian ( appropriate ) willing child undergo study procedure willing sign inform consent assent , appropriate . Less 80 % compliance either study treatment and/or study procedure ( e.g. , completion symptom ediary ) MAP0010CLP301 Study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>asthmatic child</keyword>
</DOC>